RR26 Antibody

What is RR26 Antibody and what are its primary research applications?

RR26 Antibody is a polyclonal antibody raised in rabbits against recombinant Oryza sativa subsp. japonica (Rice) RR26 protein. It is an antigen-affinity purified antibody supplied in liquid form with 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as preservative . The antibody has been validated for ELISA and Western Blot applications for identifying the RR26 antigen. While specific to rice proteins, the methodology of antibody development and validation follows standard immunological principles applicable across antibody research.

Primary applications include protein expression studies, protein localization, and functional analysis of RR26 protein in plant biology research. The antibody enables investigation of RR26 protein involvement in plant cellular processes, particularly in response to environmental stressors and developmental regulation in rice.

What are the optimal sample preparation methods when working with RR26 Antibody?

When preparing samples for RR26 Antibody applications, researchers should consider:

• Tissue extraction: Use fresh tissue when possible, with rapid freezing in liquid nitrogen followed by mechanical disruption in a suitable buffer (typically containing protease inhibitors)

• Buffer composition: For rice tissue samples, use extraction buffers containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1mM EDTA, 1% Triton X-100, and protease inhibitor cocktail

• Sample denaturation: For Western blotting, denature proteins at 95°C for 5 minutes in Laemmli buffer containing β-mercaptoethanol

• Fixation for immunohistochemistry: Use 4% paraformaldehyde in phosphate buffer for 24-48 hours, followed by standard paraffin embedding or cryosectioning procedures

The choice of sample preparation should be guided by the specific experimental goals and the nature of the target protein's subcellular localization.

What are the recommended storage conditions for maintaining RR26 Antibody activity?

To maintain optimal activity of RR26 Antibody, researchers should adhere to the following evidence-based storage protocols:

• Store at -20°C or -80°C for long-term storage

• Avoid repeated freeze-thaw cycles as they can degrade antibody quality

• For working solutions, store aliquots rather than the entire stock

• When handling, keep the antibody on ice and return to -20°C promptly after use

• Consider adding carrier proteins such as BSA (0.1-1%) for diluted working solutions to prevent adsorption to tube walls

A stability study tracking immunoreactivity over time showed that antibodies stored according to these guidelines retained >90% activity after 12 months, while those subjected to multiple freeze-thaw cycles showed significant degradation after just 3-4 cycles.

How should Western Blot protocols be optimized when using RR26 Antibody?

When optimizing Western Blot protocols with RR26 Antibody, consider the following methodological adaptations:

• Antibody dilution optimization:

  • Perform a titration experiment using dilutions from 1:500 to 1:5000

  • Evaluate signal-to-noise ratio at each dilution

  • For RR26 Antibody, optimal results are typically achieved at 1:1000-1:2000 dilutions

• Blocking optimization:

  • Test multiple blocking agents: 5% non-fat dry milk, 5% BSA, or commercial blocking buffers

  • Blocking time: 1 hour at room temperature or overnight at 4°C

  • For plant proteins, BSA often provides superior blocking compared to milk proteins

• Incubation conditions:

  • Primary antibody (RR26): Incubate overnight at 4°C with gentle agitation

  • Secondary antibody: Anti-rabbit HRP conjugate at 1:5000-1:10000 for 1 hour at room temperature

• Buffer composition:

  • TBST (TBS + 0.1% Tween-20) is recommended for washing steps

  • Perform 3-5 washes of 5-10 minutes each between antibody incubations

This methodological approach helps minimize background while maximizing specific signal detection for RR26 protein analysis.

What validation controls should be implemented when using RR26 Antibody?

Implementing proper validation controls is essential for ensuring reliable results with RR26 Antibody:

When antibody validation reveals inconsistencies, researchers should systematically evaluate each parameter, starting with sample preparation and progressing through blocking conditions, antibody concentrations, and detection methods.

How can cross-reactivity be assessed when using RR26 Antibody across different plant species?

Assessing cross-reactivity of RR26 Antibody requires a systematic approach:

• Sequence homology analysis:

  • Perform BLASTp alignment of RR26 protein sequence against target species

  • Focus on the immunogen region (amino acids targeted by the antibody)

  • Calculate percent identity and similarity scores

• Epitope conservation evaluation:

  • Map the specific epitope region recognized by RR26 Antibody

  • Analyze conservation of critical residues across species

  • Predict potential cross-reactivity based on epitope conservation

• Experimental validation:

  • Test antibody against protein extracts from multiple species in Western blot

  • Include positive control (rice extract) alongside test species

  • Document band patterns and molecular weights across species

• Specificity confirmation:

  • Perform immunoprecipitation followed by mass spectrometry

  • Validate that pulled-down proteins match expected targets

  • Document any off-target binding for comprehensive characterization

While RR26 Antibody is specifically raised against rice proteins, researchers investigating related proteins in other plant species should evaluate sequence conservation at the immunogen region (Q5N6V8) to predict potential cross-reactivity .

What are common challenges and solutions when using RR26 Antibody in immunohistochemistry?

When implementing RR26 Antibody in immunohistochemistry (IHC), researchers commonly encounter these challenges and methodological solutions:

• High background signal:

  • Challenge: Non-specific binding to endogenous plant compounds

  • Solution: Pre-absorb antibody with plant extract powder; increase blocking with 10% normal serum; implement additional washing steps with 0.3% Triton X-100

• Weak or absent signal:

  • Challenge: Epitope masking during fixation

  • Solution: Test multiple antigen retrieval methods (heat-induced at pH 6.0, 9.0; enzymatic with proteinase K); optimize fixation time (reduce to 12-24 hours for plant tissues)

• Autofluorescence interference:

  • Challenge: Plant tissues often display strong autofluorescence

  • Solution: Pre-treat sections with 0.1% sodium borohydride; use Sudan Black B (0.1% in 70% ethanol) post-staining; consider spectral unmixing during imaging

• Inconsistent staining across tissue:

  • Challenge: Uneven penetration in dense plant tissues

  • Solution: Optimize section thickness (8-10 μm optimal); vacuum infiltration of reagents; extend incubation times with gentle agitation

Researchers should systematically document all optimization steps through a controlled experimental design, modifying one variable at a time while maintaining others constant.

How can non-specific binding be reduced when working with RR26 Antibody?

Reducing non-specific binding requires a multi-faceted approach with specific methodological adjustments:

• Pre-adsorption protocol:

  • Dilute RR26 Antibody to working concentration

  • Add 100-200 μg/ml of non-related plant extract powder

  • Incubate for 2 hours at room temperature with gentle rotation

  • Centrifuge at 10,000g for 10 minutes and use supernatant for experiments

• Blocking optimization:

  • Test multiple blocking agents (BSA, normal serum, commercial blockers)

  • Extend blocking time to 2-3 hours at room temperature

  • Include 0.1-0.3% Triton X-100 in blocking buffer to reduce hydrophobic interactions

• Buffer modifications:

  • Add 0.1-0.5M NaCl to reduce ionic interactions

  • Include 0.1% non-ionic detergent (Tween-20 or Triton X-100)

  • Consider adding 5-10% polyethylene glycol (PEG) to reduce non-specific adsorption

• Antibody handling:

  • Centrifuge antibody solution (14,000g for 10 minutes) before use to remove aggregates

  • Use freshly prepared antibody dilutions

  • Filter diluted antibody through 0.22 μm filter before application

These methodological adjustments should be implemented sequentially, evaluating the impact of each change through comparison with control conditions.

How can RR26 Antibody be integrated into multi-parameter proteomic analyses?

Integrating RR26 Antibody into multi-parameter analyses requires sophisticated methodological approaches:

• Multiplexed immunofluorescence:

  • Combine RR26 Antibody with antibodies against other proteins of interest

  • Ensure primary antibodies are raised in different host species

  • Use spectrally distinct fluorophore-conjugated secondary antibodies

  • Implement spectral unmixing to resolve overlapping fluorescence emissions

• Sequential immunoblotting:

  • Perform detection with RR26 Antibody first

  • Document results thoroughly

  • Strip membrane using validated stripping buffer (200mM glycine, 0.1% SDS, 1% Tween-20, pH 2.2)

  • Re-probe with additional antibodies against other proteins

  • Validate that stripping does not affect subsequent detection efficiency

• Proximity ligation assay (PLA) applications:

  • Combine RR26 Antibody with antibodies against potential interaction partners

  • Use species-specific PLA probes

  • Optimize probe dilution and incubation times for plant tissue samples

  • Quantify interaction signals using appropriate image analysis software

• Mass spectrometry integration:

  • Use RR26 Antibody for immunoprecipitation

  • Analyze precipitated complexes by LC-MS/MS

  • Implement appropriate controls (IgG pulldown, input sample)

  • Apply statistical analysis to identify significant interactions

These advanced applications extend beyond basic detection to provide insights into protein interactions, co-localization, and functional relationships in complex biological systems.

What methodological approaches can address contradictory results when using RR26 Antibody across different experimental platforms?

When faced with contradictory results across experimental platforms using RR26 Antibody, implement this systematic troubleshooting methodology:

• Comprehensive antibody validation:

  • Perform epitope mapping to identify the exact binding region

  • Test antibody recognition under native and denatured conditions

  • Evaluate potential post-translational modification interference

  • Document lot-to-lot variation through parallel testing

• Cross-platform standardization:

  • Prepare a standard sample set to be used across all platforms

  • Process identical samples in parallel through different methodologies

  • Implement consistent blocking and washing protocols across platforms

  • Standardize image acquisition and analysis parameters

• Systematic variable isolation:

  • Create a matrix of experimental conditions

  • Vary one parameter at a time (fixation, permeabilization, antibody concentration)

  • Document the impact of each variable on results

  • Identify critical parameters affecting outcome consistency

• Orthogonal validation:

  • Implement alternative detection methods (e.g., MS validation of Western blot results)

  • Use genetic approaches (overexpression, knockdown) to validate antibody specificity

  • Apply complementary techniques (immunofluorescence and in situ hybridization)

  • Correlate protein detection with transcript levels (RT-qPCR)

By systematically addressing each potential variable, researchers can identify the source of discrepancies and develop standardized protocols that yield consistent results across platforms.

How does the performance of polyclonal RR26 Antibody compare with monoclonal alternatives for advanced research applications?

A comparative analysis of polyclonal RR26 Antibody versus monoclonal alternatives reveals distinct performance characteristics relevant for advanced research:

For advanced spatial proteomics or single-cell applications, the choice between polyclonal RR26 Antibody and monoclonal alternatives should be guided by the specific research question, particularly regarding the need for sensitivity versus absolute specificity.

How can RR26 Antibody be adapted for use in advanced imaging techniques like super-resolution microscopy?

Adapting RR26 Antibody for super-resolution microscopy requires specific methodological considerations:

• Conjugation strategies for direct fluorophore labeling:

  • Use NHS-ester chemistry to label primary amines on RR26 Antibody

  • Optimal dye-to-antibody ratio: 2-4 fluorophores per antibody molecule

  • Recommended fluorophores: Alexa Fluor 647, Cy5.5, or ATTO 488 for STORM/PALM

  • Validate that conjugation does not impair antigen recognition through parallel testing

• Sample preparation optimization:

  • Use thinner sections (4-5 μm) to minimize out-of-focus signal

  • Implement dual fixation (2% paraformaldehyde followed by 0.2% glutaraldehyde)

  • Apply graduated ethanol series for dehydration to preserve cellular ultrastructure

  • Mount in specialized imaging media with appropriate refractive index matching

• Protocol adaptations for different super-resolution modalities:

  • STORM/PALM: Use oxygen scavenging buffer systems containing glucose oxidase/catalase

  • STED: Select fluorophores with high photostability (ATTO dyes preferred)

  • SIM: Increase antibody concentration by 20-30% compared to conventional immunofluorescence

  • Expansion microscopy: Test RR26 Antibody retention after polymer expansion

• Validation and controls:

  • Implement fiducial markers for drift correction

  • Use multicolor beads for chromatic aberration calibration

  • Include known structural proteins as positive controls for resolution verification

  • Quantify localization precision using repeated localizations of single fluorophores

These methodological adaptations enable researchers to leverage the specificity of RR26 Antibody while achieving nanoscale resolution of target structures.

What considerations should guide the use of RR26 Antibody in CRISPR-based knockout validation studies?

When integrating RR26 Antibody into CRISPR-based knockout validation studies, researchers should follow these methodological guidelines:

• Strategic epitope mapping in relation to CRISPR target sites:

  • Determine the exact epitope region recognized by RR26 Antibody

  • Design CRISPR guide RNAs to target genomic regions encoding this epitope

  • Create additional guide RNAs targeting distant regions as controls

  • Validate the relationship between edit location and antibody binding

• Sequential validation approach:

  • Confirm genomic edits through sequencing

  • Assess transcript disruption via RT-qPCR

  • Evaluate protein loss using RR26 Antibody in Western blot

  • Perform immunostaining to confirm cellular phenotype

• Controls for specificity assessment:

  • Include wild-type samples as positive controls

  • Implement multiple independent CRISPR clones

  • Use RR26 siRNA knockdown samples as specificity controls

  • Develop rescue experiments reintroducing the target protein

• Quantitative analysis protocols:

  • Standardize protein quantification methods

  • Implement digital image analysis with consistent thresholding

  • Calculate signal reduction percentages relative to controls

  • Correlate protein reduction with genomic editing efficiency

This methodological framework ensures that RR26 Antibody serves as a reliable tool for validating CRISPR-mediated gene disruption while controlling for potential artifacts or non-specific signals.